ICCAD - International Congress on Innovations in Coronary Artery Disease

  • Casa
  • Italia
  • Venice
  • ICCAD - International Congress on Innovations in Coronary Artery Disease

ICCAD - International Congress on Innovations in Coronary Artery Disease ICCAD receives over 800 abstracts. Make sure to submit yours for the first group of reviews by our in

The 12th International Congress on Innovations in Coronary Artery Disease – From Prevention to Intervention (ICCAD) will take place in Venice, Italy from 15-17 October, 2017. Venice ICCAD will follow the format of the very successful previous ICCAD meetings and will provide a comprehensive bench to bedside update on coronary artery disease in all its aspects. The scientific program of ICCAD 2017 is being planned with the collaboration and endorsement of the ESC Working Group for Cardiovascular Pharmacotherapy and other prestigious groups. Keynote lectures will be delivered by a distinguished international faculty, while a large number of selected free communications will report new data from basic research laboratories and clinical centers around the globe. The ICCAD program will include sessions on basic research, stem cell research and myocardial repair, vascular biology and clinical cardiology. We will also dedicate sessions to new advances in pharmacotherapy, especially to the current challenges in antithrombotic and antiplatelet therapy and to the new drugs in lipidology and diabetes which may so dramatically change the outcome and improve the prognosis. We will also discuss the latest news in interventional cardiology, stents and strategies, including the challenge of concomitant carotid and peripheral vascular disease, the rapidly expanding field of valvular interventions, and the role of the heart team and surgical management of coronary and cardiovascular disease.

23/07/2017

Plans for ICCAD 2017 are progressing extremely well. Register and book your accommodtion now. Rooms at the special rates are limited. See you in Venice!!

Submit your Abstract and Celebrate 20 Years of ICCAD with us in VeniceHot sessions will include Stem Cell Therapy, Molec...
23/05/2017

Submit your Abstract and Celebrate 20 Years of ICCAD with us in Venice

Hot sessions will include Stem Cell Therapy, Molecular Biology, Acute Coronary Syndromes, Acute Myocardial Infarction, Interventional Cardiology, Cardiac Surgery, TAVI, Valves, New Management of Lipidology and Diabetes,Pharmacotherapy,
Thrombosis Update and Thrombosis Summit
www.iccadcongress.com

12th International Congress, ICCAD 2017, which deals with atherosclerosis, angina pectoris, heart failure, coronary artery disease, myocardial ischemia, etc

What is the Role of Intravascular Imaging to Individualise Secondary Prevention?Meet Prof. Carlo di Mario from the Unive...
05/04/2017

What is the Role of Intravascular Imaging to Individualise Secondary Prevention?

Meet Prof. Carlo di Mario from the University of Firenze at the 12th International Congress on Innovations in Coronary Artery Disease, October 15-17, 2017, Venice, Italy. Do not miss out! Register now – www.iccadcongress.com

First-degree relatives of patients with early-onset CAD who are healthy individuals were found to have a higher coronary...
05/02/2017

First-degree relatives of patients with early-onset CAD who are healthy individuals were found to have a higher coronary plaque burden than patients with CAD symptoms, researchers reported.

Submit your abstract for ICCAD 2017 and share your work in front of cardiologists, researchers and key opinion leaders.
www.iccadcongress.com

First-degree relatives of patients with early-onset CAD who are healthy individuals were found to have a higher coronary plaque burden than patients with CAD symptoms, researchers reported. The healthy relatives also had more unfavorable plaque features compared with symptomatic patients, Morten K.…

  Meet our International Faculty:  Dr. Udho ThadaniDr. Thadani is from the University of Oklahoma, USA and will discuss ...
13/01/2017

Meet our International Faculty: Dr. Udho Thadani

Dr. Thadani is from the University of Oklahoma, USA and will discuss "Management of Stable Angina 2017: A Critical Appraisal" at ICCAD2017 – 12th International Congress on Innovations in Coronary Artery Disease.

Join him, register today: www.iccadcongress.com

  Wishes you a Healthy, Happy and Prosperous New Year. Submit your abstract today and be part of the future on innovatio...
22/12/2016

Wishes you a Healthy, Happy and Prosperous New Year.

Submit your abstract today and be part of the future on innovations in coronary artery disease.

www.iccadcongress.com

A 2016 study investigated the effect of continuous positive airway pressure on cardiovascular risk in coronary artery di...
01/12/2016

A 2016 study investigated the effect of continuous positive airway pressure on cardiovascular risk in coronary artery disease patients with non-sleepy obstructive sleep apnea. No significant benefit was found with continuous positive airway pressure use overall compared to non-use.

Submit your abstract for ICCAD 2017 and share your work in front of cardiologists, researchers and key opinion leaders.
www.iccadcongress.com

A 2016 study investigated the effect of continuous positive airway pressure on cardiovascular risk in coronary artery disease patients with non-sleepy obstructive sleep apnea. No significant benefit was found with continuous positive airway pressure use overall compared to non-use.

In individuals with high genetic risk, those with a favorable lifestyle focusing on no smoking, no obesity, regular phys...
28/11/2016

In individuals with high genetic risk, those with a favorable lifestyle focusing on no smoking, no obesity, regular physical activity and a healthy diet were less likely to develop CAD compared with those with an unfavorable lifestyle, according to data presented at the American Heart Association Scientific Sessions.

Register early and save – www.iccadcongress.com

NEW ORLEANS — In individuals with high genetic risk, those with a favorable lifestyle focusing on no smoking, no obesity, regular physical activity and a healthy diet were less likely to develop CAD compared with those with an unfavorable lifestyle, according to data presented at the American…

Patients who suffer from coronary heart disease may benefit from a new technology that props open arteries, lets blood f...
22/11/2016

Patients who suffer from coronary heart disease may benefit from a new technology that props open arteries, lets blood flow through and dissolves once the vessel is healed.

Contribute your knowledge and expertise at ICCAD 2017.
Submit your abstract today and make a difference!
www.iccadcongress.com

Patients who suffer from coronary heart disease may benefit from a new technology that props open arteries, lets blood flow through and dissolves once the vessel is healed. Coronary heart disease is responsible for an estimated 370,000 deaths each year in the United States, according to the National...

30/10/2016

Happy Diwali to all celebrating. May millions of lamps illuminate your life with endless joy, prosperity, health & wealth forever.

   What are the Congress Learning Objectives?Contribute your knowledge and expertise at ICCAD 2017. Submit your abstract...
18/10/2016

What are the Congress Learning Objectives?

Contribute your knowledge and expertise at ICCAD 2017.
Submit your abstract today and make a difference!
www.iccadcongress.com

28/09/2016

ICCAD will be celebrating 20 years in 2017. Join us for a spectacular congress. We have given the congress a face lift, amazing program and so much more. Follow us for updates.

Indirizzo

Giudecca 810
Venice

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando ICCAD - International Congress on Innovations in Coronary Artery Disease pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a ICCAD - International Congress on Innovations in Coronary Artery Disease:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram